跳至主要内容
临床试验/NCT04396158
NCT04396158Unknown不适用

Effect of Radioiodine Therapy on Ovarian Reserve in Female Patients With Differentiated Thyroid Cancer

Assiut University0 个研究点目标入组 38 人开始时间: 2020年6月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
38
主要终点
Level of anti-Müllerian (AMH) hormone

研究概览

简要总结

Thyroid carcinoma is the most common endocrine malignancy. Surgery is the standard therapeutic approach for patients with differentiated thyroid carcinoma (DTC), followed by radioiodine (RAI) therapy if indicated. For women with DTC, the effects of RAI therapy on gonadal and reproductive function are an important consideration. This study aimed to evaluate the effects of RAI therapy on ovarian function.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
15 Years 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patient in childbearing period.
  • Female patient with differentiated thyroid carcinoma.
  • Underwent thyroidectomy.
  • Candidate for radioactive iodine therapy.

排除标准

  • • Male patients.
  • Postmenopausal female patients.
  • Female patients with undifferentiated thyroid carcinoma.
  • Pregnant female patients.
  • Lactating female patients.

结局指标

主要结局

Level of anti-Müllerian (AMH) hormone

时间窗: 6 months

Level of anti-Müllerian (AMH) hormone in female patients before and after radioactive iodine therapy.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hebat Allah Ahmed Askar

Lecturer of nuclear medicine

Assiut University

相似试验

Effect of Radioiodine Therapy on Ovarian Reserve in... | 临床试验